PDCD1 and neoplasm: In a high tumor burden setting, designed to foster T cell exhaustion, we observed that TCRED-LAG-3KO cells infiltrating the bone marrow in conditions of antigen persistence display a reduced induction of compensatory inhibitory molecules (CTLA-4, PD-1 and TIM-3), thus further supporting our in vitro findings.